Jci_page_head_homepage_01 Jci_page_head_homepage_02
Sang Sun Yoon, Ray Coakley, Gee W. Lau, Sergei V. Lymar, Benjamin Gaston, Ahmet C. Karabulut, Robert F. Hennigan, Sung-Hei Hwang, Garry Buettner, Michael J. Schurr, Joel E. Mortensen, Jane L. Burns, David Speert, Richard C. Boucher, Daniel J. Hassett
Published in Volume 116, Issue 2
J Clin Invest. 2006; 116(2):436–446 doi:10.1172/JCI24684
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 3
HNO2 sensitivity of 94 different mucoid CF clinical isolates of P. aeruginosa.

Aerobic starter cultures of each strain were diluted 100-fold in LB (pH 6.5) supplemented with 15 mM NO2. The CFU in the inoculum versus that after a 4-day anaerobic incubation were determined. The values for log10 [CFUafter 4 days/CFUinoculum] were calculated and are plotted as the viability index. The mucA gene of each isolate was sequenced, and mucoid strains with wild-type mucA alleles and those harboring mucA mutation were shown at left and right, respectively. Arrows indicate clinical isolates that were found to be highly resistant to amikacin, aztreonam, cefepime, ceftazidime, ciprofloxacin, gentamycin, imipenem, and tobramycin.